At Polar NanoPharma, we are dedicated to revolutionizing cancer treatment through our cutting-edge nanotechnology platform. This innovative platform allows for the encapsulation of a wide range of drugs without chemical modification, delivering them with precision to tumor sites and enabling intracellular drug release. Our advanced approach not only aims to improve treatment outcomes but also to significantly reduce side effects, paving the way for a brighter future in oncology care.

Supported & incubated by: 
- Acelera Start Up program by Impact Hub / EOI
- EAE Emprendre by EAE Business School
- Healthcare Vallès by CECOT

Polar NanoPharma

Org chart

Teams

Offices